Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal Immunogenicity.

Jilek JL, Zhang QY, Tu MJ, Ho PY, Duan Z, Qiu JX, Yu AM.

Mol Ther Nucleic Acids. 2019 Jan 24;14:498-508. doi: 10.1016/j.omtn.2019.01.007. [Epub ahead of print]

2.

[Study on the correlation between meteorological factors and allergic rhinitis in outpatients in Yangzhou].

Sun HY, Guan B, Yu AM.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Nov;32(22):1731-17734. doi: 10.13201/j.issn.1001-1781.2018.22.012. Chinese.

PMID:
30716806
3.

A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma.

Alegre F, Ormonde AR, Snider KM, Woolard K, Yu AM, Wittenburg LA.

PLoS One. 2018 Dec 31;13(12):e0209941. doi: 10.1371/journal.pone.0209941. eCollection 2018.

4.

Atopic eczema and major cardiovascular outcomes: A systematic review and meta-analysis of population-based studies.

Ascott A, Mulick A, Yu AM, Prieto-Merino D, Schmidt M, Abuabara K, Smeeth L, Roberts A, Langan SM.

J Allergy Clin Immunol. 2018 Dec 18. pii: S0091-6749(18)32728-3. doi: 10.1016/j.jaci.2018.11.030. [Epub ahead of print]

5.

[Two cases of piriform pit carcinoma were repaired with thyroid lobe].

Shi SJ, Yu AM, Guan B, Wang MH, Dai BY, Yan Q.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Oct 5;32(19):1511-1514. doi: 10.13201/j.issn.1001-1781.2018.19.019. Chinese.

PMID:
30550202
6.

RNA therapy: Are we using the right molecules?

Yu AM, Jian C, Yu AH, Tu MJ.

Pharmacol Ther. 2018 Dec 4. pii: S0163-7258(18)30216-X. doi: 10.1016/j.pharmthera.2018.11.011. [Epub ahead of print] Review.

7.

Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models.

Tu MJ, Ho PY, Zhang QY, Jian C, Qiu JX, Kim EJ, Bold RJ, Gonzalez FJ, Bi H, Yu AM.

Cancer Lett. 2019 Feb 1;442:82-90. doi: 10.1016/j.canlet.2018.10.038. Epub 2018 Oct 30.

PMID:
30389433
8.

SnapShot: RNA Structure Probing Technologies.

Carlson PD, Evans ME, Yu AM, Strobel EJ, Lucks JB.

Cell. 2018 Oct 4;175(2):600-600.e1. doi: 10.1016/j.cell.2018.09.024.

PMID:
30290145
9.

Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis.

Kovic B, Jin X, Kennedy SA, Hylands M, Pedziwiatr M, Kuriyama A, Gomaa H, Lee Y, Katsura M, Tada M, Hong BY, Cho SM, Hong PJ, Yu AM, Sivji Y, Toma A, Xie L, Tsoi L, Waligora M, Prasad M, Bhatnagar N, Thabane L, Brundage M, Guyatt G, Xie F.

JAMA Intern Med. 2018 Dec 1;178(12):1586-1596. doi: 10.1001/jamainternmed.2018.4710.

PMID:
30285081
10.

Laparoscopic metabolic surgery for the treatment of type 2 diabetes in Asia: a scoping review and evidence-based analysis.

Dong Z, Islam SMS, Yu AM, Qu R, Guan B, Zhang J, Hong Z, Wang C.

BMC Surg. 2018 Sep 17;18(1):73. doi: 10.1186/s12893-018-0406-3. Review.

11.

Weight loss surgery for obstructive sleep apnoea with obesity in adults: a systematic review and meta-analysis protocol.

Dong Z, Hong BY, Yu AM, Cathey J, Shariful Islam SM, Wang C.

BMJ Open. 2018 Aug 29;8(8):e020876. doi: 10.1136/bmjopen-2017-020876.

12.

High-throughput determination of RNA structures.

Strobel EJ, Yu AM, Lucks JB.

Nat Rev Genet. 2018 Oct;19(10):615-634. doi: 10.1038/s41576-018-0034-x. Review.

PMID:
30054568
13.

Pediatric Wells syndrome (eosinophilic cellulitis) after vaccination: A case report and review of the literature.

Yu AM, Ito S, Leibson T, Lavi S, Fu LW, Weinstein M, Skotnicki SM.

Pediatr Dermatol. 2018 Sep;35(5):e262-e264. doi: 10.1111/pde.13532. Epub 2018 Jul 12. Review.

PMID:
29998475
14.

Reporting of interventions and "standard of care" control arms in pediatric clinical trials: a quantitative analysis.

Yu AM, Balasubramanaiam B, Offringa M, Kelly LE.

Pediatr Res. 2018 Sep;84(3):393-398. doi: 10.1038/s41390-018-0019-7. Epub 2018 Jun 13.

PMID:
29899384
15.

Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo.

Zhang QY, Ho PY, Tu MJ, Jilek JL, Chen QX, Zeng S, Yu AM.

Int J Pharm. 2018 Aug 25;547(1-2):537-544. doi: 10.1016/j.ijpharm.2018.06.026. Epub 2018 Jun 9.

PMID:
29894758
16.

[Analysis of the recurrence related factors of sinonasal inverted papilloma].

Wang MH, Guan B, Yu AM, Dai BY, Yan Q, Chen SS.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Dec 20;31(24):1927-1930. doi: 10.13201/j.issn.1001-1781.2017.24.014. Chinese.

PMID:
29798318
17.

[The clinical research of arytenoid dislocation].

Jiao C, Cao Q, Yan Q, Leng L, Yu AM.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Nov 20;31(22):1767-1769. doi: 10.13201/j.issn.1001-1781.2017.22.017. Chinese. No abstract available.

PMID:
29798196
18.

Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy.

Ho PY, Duan Z, Batra N, Jilek JL, Tu MJ, Qiu JX, Hu Z, Wun T, Lara PN, DeVere White RW, Chen HW, Yu AM.

J Pharmacol Exp Ther. 2018 Jun;365(3):494-506. doi: 10.1124/jpet.118.247775. Epub 2018 Mar 30.

PMID:
29602831
19.

Systematic review of atopic dermatitis disease definition in studies using routinely collected health data.

Dizon MP, Yu AM, Singh RK, Wan J, Chren MM, Flohr C, Silverberg JI, Margolis DJ, Langan SM, Abuabara K.

Br J Dermatol. 2018 Jun;178(6):1280-1287. doi: 10.1111/bjd.16340. Epub 2018 Apr 25. Review.

20.

[A case of rare spontaneous hematoma in the neck].

Guo SQ, Yu AM, Guan B.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Nov 7;52(11):861-862. doi: 10.3760/cma.j.issn.1673-0860.2017.11.016. Chinese. No abstract available.

PMID:
29141302
21.

Secondary structure forming sequences drive SD-MMEJ repair of DNA double-strand breaks.

Khodaverdian VY, Hanscom T, Yu AM, Yu TL, Mak V, Brown AJ, Roberts SA, McVey M.

Nucleic Acids Res. 2017 Dec 15;45(22):12848-12861. doi: 10.1093/nar/gkx1056.

22.

Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.

Li PC, Tu MJ, Ho PY, Jilek JL, Duan Z, Zhang QY, Yu AX, Yu AM.

Drug Metab Dispos. 2018 Jan;46(1):2-10. doi: 10.1124/dmd.117.078741. Epub 2017 Oct 23.

23.

Association between eczema and major cardiovascular outcomes in population-based studies: a systematic review protocol.

Ascott A, Yu AM, Schmidt M, Abuabara K, Smeeth L, Langan SM.

BMJ Open. 2017 Sep 29;7(9):e017979. doi: 10.1136/bmjopen-2017-017979.

24.

The prevalence of atopic dermatitis beyond childhood: A systematic review and meta-analysis of longitudinal studies.

Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM.

Allergy. 2018 Mar;73(3):696-704. doi: 10.1111/all.13320. Epub 2017 Nov 24.

25.

Stop this waste of people, animals and money.

Moher D, Shamseer L, Cobey KD, Lalu MM, Galipeau J, Avey MT, Ahmadzai N, Alabousi M, Barbeau P, Beck A, Daniel R, Frank R, Ghannad M, Hamel C, Hersi M, Hutton B, Isupov I, McGrath TA, McInnes MDF, Page MJ, Pratt M, Pussegoda K, Shea B, Srivastava A, Stevens A, Thavorn K, van Katwyk S, Ward R, Wolfe D, Yazdi F, Yu AM, Ziai H.

Nature. 2017 Sep 6;549(7670):23-25. doi: 10.1038/549023a. No abstract available.

PMID:
28880300
26.

Nanopore sequencing in microgravity.

McIntyre ABR, Rizzardi L, Yu AM, Alexander N, Rosen GL, Botkin DJ, Stahl SE, John KK, Castro-Wallace SL, McGrath K, Burton AS, Feinberg AP, Mason CE.

NPJ Microgravity. 2016 Oct 20;2:16035. doi: 10.1038/npjmgrav.2016.35. eCollection 2016.

27.

Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models.

Jian C, Tu MJ, Ho PY, Duan Z, Zhang Q, Qiu JX, DeVere White RW, Wun T, Lara PN, Lam KS, Yu AX, Yu AM.

Oncotarget. 2017 May 9;8(19):30742-30755. doi: 10.18632/oncotarget.16372.

28.

Conclusions about atopic dermatitis persistence might be premature.

Abuabara K, Langan SM, Yu AM.

J Am Acad Dermatol. 2017 May;76(5):e177-e178. doi: 10.1016/j.jaad.2016.11.067. No abstract available.

PMID:
28411793
29.

Regulation of drug metabolism and toxicity by multiple factors of genetics, epigenetics, lncRNAs, gut microbiota, and diseases: a meeting report of the 21st International Symposium on Microsomes and Drug Oxidations (MDO).

Yu AM, Ingelman-Sundberg M, Cherrington NJ, Aleksunes LM, Zanger UM, Xie W, Jeong H, Morgan ET, Turnbaugh PJ, Klaassen CD, Bhatt AP, Redinbo MR, Hao P, Waxman DJ, Wang L, Zhong XB.

Acta Pharm Sin B. 2017 Mar;7(2):241-248. doi: 10.1016/j.apsb.2016.12.006. Epub 2017 Feb 1.

30.

PPARα regulates tumor cell proliferation and senescence via a novel target gene carnitine palmitoyltransferase 1C.

Chen Y, Wang Y, Huang Y, Zeng H, Hu B, Guan L, Zhang H, Yu AM, Johnson CH, Gonzalez FJ, Huang M, Bi H.

Carcinogenesis. 2017 Apr 1;38(4):474-483. doi: 10.1093/carcin/bgx023.

31.

Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling.

Francois LN, Gorczyca L, Du J, Bircsak KM, Yen E, Wen X, Tu MJ, Yu AM, Illsley NP, Zamudio S, Aleksunes LM.

Placenta. 2017 Mar;51:57-63. doi: 10.1016/j.placenta.2017.01.125. Epub 2017 Jan 24.

32.

Effects of MicroRNA-34a on the Pharmacokinetics of Cytochrome P450 Probe Drugs in Mice.

Jilek JL, Tian Y, Yu AM.

Drug Metab Dispos. 2017 May;45(5):512-522. doi: 10.1124/dmd.116.074344. Epub 2017 Mar 2.

33.

Comparing early liver graft function from heart beating and living-donors: A pilot study aiming to identify new biomarkers of liver injury.

Yang QJ, Kluger M, Goryński K, Pawliszyn J, Bojko B, Yu AM, Noh K, Selzner M, Jerath A, McCluskey S, Pang KS, Wąsowicz M.

Biopharm Drug Dispos. 2017 Jul;38(5):326-339. doi: 10.1002/bdd.2066. Epub 2017 Apr 6.

PMID:
28102538
34.

TRAP-seq Profiling and RNAi-Based Genetic Screens Identify Conserved Glial Genes Required for Adult Drosophila Behavior.

Ng FS, Sengupta S, Huang Y, Yu AM, You S, Roberts MA, Iyer LK, Yang Y, Jackson FR.

Front Mol Neurosci. 2016 Dec 22;9:146. doi: 10.3389/fnmol.2016.00146. eCollection 2016.

35.

Lyme disease spirochaete Borrelia burgdorferi does not require thiamin.

Zhang K, Bian J, Deng Y, Smith A, Nunez RE, Li MB, Pal U, Yu AM, Qiu W, Ealick SE, Li C.

Nat Microbiol. 2016 Nov 21;2:16213. doi: 10.1038/nmicrobiol.2016.213.

36.

Cotranscriptional folding of a riboswitch at nucleotide resolution.

Watters KE, Strobel EJ, Yu AM, Lis JT, Lucks JB.

Nat Struct Mol Biol. 2016 Dec;23(12):1124-1131. doi: 10.1038/nsmb.3316. Epub 2016 Oct 31.

37.

[The effect of nasal endoscopic surgery in the treatment of acuteinvasive fungal rhino-sinusitis in 5 cases].

Cao W, Guan B, Yu AM, Kafle S, Dai BY.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Oct 20;30(20):1647-1649. doi: 10.13201/j.issn.1001-1781.2016.20.016. Chinese. No abstract available.

PMID:
29871164
38.

Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice.

Jiang XL, Shen HW, Mager DE, Schmidt S, Yu AM.

Acta Pharm Sin B. 2016 Sep;6(5):492-503. Epub 2016 Aug 6.

39.

Advanced knowledge in drug metabolism and pharmacokinetics.

Yu AM, Zhong XB.

Acta Pharm Sin B. 2016 Sep;6(5):361-362. Epub 2016 Sep 28. No abstract available.

40.

Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells.

Rodrigues AC, Neri EA, Veríssimo-Filho S, Rebouças NA, Hirata RD, Yu AM.

Eur J Pharm Sci. 2016 Oct 10;93:431-6. doi: 10.1016/j.ejps.2016.08.044. Epub 2016 Aug 26.

41.

Bioengineered non-coding RNA agent (BERA) in action.

Duan Z, Yu AM.

Bioengineered. 2016 Nov;7(6):411-417. doi: 10.1080/21655979.2016.1207011. Epub 2016 Jul 14. Review.

42.

MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis.

Tu MJ, Pan YZ, Qiu JX, Kim EJ, Yu AM.

Oncotarget. 2016 Jul 19;7(29):45547-45561. doi: 10.18632/oncotarget.9999.

43.
44.

The Mbd4 DNA glycosylase protects mice from inflammation-driven colon cancer and tissue injury.

Yu AM, Calvo JA, Muthupalani S, Samson LD.

Oncotarget. 2016 May 10;7(19):28624-36. doi: 10.18632/oncotarget.8721.

45.

Characterizing RNA structures in vitro and in vivo with selective 2'-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-Seq).

Watters KE, Yu AM, Strobel EJ, Settle AH, Lucks JB.

Methods. 2016 Jul 1;103:34-48. doi: 10.1016/j.ymeth.2016.04.002. Epub 2016 Apr 12.

46.
47.

Exercise Responses to Gravity-Independent Flywheel Aerobic and Resistance Training.

Owerkowicz T, Cotter JA, Haddad F, Yu AM, Camilon ML, Hoang TN, Jimenez DJ, Kreitenberg A, Tesch PA, Caiozzo VJ, Adams GR.

Aerosp Med Hum Perform. 2016 Feb;87(2):93-101. doi: 10.3357/AMHP.4229.2016.

48.

Bioengineering of noncoding RNAs for research agents and therapeutics.

Ho PY, Yu AM.

Wiley Interdiscip Rev RNA. 2016 Mar-Apr;7(2):186-97. doi: 10.1002/wrna.1324. Epub 2016 Jan 13. Review.

49.

MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Yu AM, Tian Y, Tu MJ, Ho PY, Jilek JL.

Drug Metab Dispos. 2016 Mar;44(3):308-19. doi: 10.1124/dmd.115.067470. Epub 2015 Nov 13. Review.

50.

Occupational Airborne Contact Dermatitis From Proton Pump Inhibitors.

DeKoven JG, Yu AM.

Dermatitis. 2015 Nov-Dec;26(6):287-90. doi: 10.1097/DER.0000000000000139.

PMID:
26551609

Supplemental Content

Support Center